Dr. Dagan has more than twenty five years of experience as a BioTech executive, in management, operations, sales and finance with track record generating high multiple growth of BioTechnology public and private companies in the US and Israel.
From 2005 to 2017 involved in starting a dozen Medical Device and pharma companies. In each company hands on involvement, as an active manager, board member or chairman of the board. The last involvement is with Generex Biotechnology a US registered public company, that is being reformed in the Pharma and Biomedical devices arena.
Member on the Board of Governors, of the Technion-Israel Institute of Technology.
Dr. Dagan received his Doctorate from Columbia University where his research focused on Nuclear Medicine applications in Cardiology. An MSc in Nuclear Sciences from the Technion. And a B.Sc. in Mechanical and Nuclear Engineering from the Technion, Israel Inst. of Technology.
Dr. Jacob Dagan is senior Management director for NYC Audiology.